About Jeff Ellis

This author has not yet filled in any details.
So far Jeff Ellis has created 1 blog entries.

Cellaca: Brightfield vs Fluorescence Cell Counting

Download the Flyer Flyer: Cell Counting - Are You Using the Right Method? Brightfield vs Fluorescence. Fit-for-purpose methodologies are critical to researchers seeking accurate results. Inaccurate results fromchoosing the wrong cell counting method can lead to consequences such as lower quality of products, rejectedpublications, repeated experiments, and lost time. U.S. Congress as well as the National Institute of Standards and Technology (NIST), and other stakeholders, haveidentified that cell counting and viability measurement assurance are important standards for improving thequality of cell therapy products.

By |2022-07-12T15:15:16+00:00July 11th, 2022|0 Comments

T cell immunotherapy workflow improvements for clinical-grade manufacturing

Cell-based treatments are life-saving therapies with the potential to offer cures for cancers and other diseases.

Poster: High-throughput chemotherapeutic drug screening of tumor spheroids with individual spheroid results using image cytometry

Download the Poster High-throughput chemotherapeutic drug screening of tumor spheroids with individual spheroid results using image cytometry Jordan Bell, Shilpaa Mukundan, Matthew Teryek, Bo Lin, Biju Parekkadan, Sun Yung, Suzanne Riches, and Leo Li-Ying ChanThree-dimensional cancer models have gained popularity for in vitro studies of chemotherapeutic compounds by providing a more physiologically relevant analog of gas, nutrient, and drug diffusion throughout the tumor microenvironment. Some 3D assays are performed to study individual spheroids over time, where most of these assays rely on maintaining a single spheroid in each well of a 96-well round-bottom ultra-low attachment plate, limiting the number of [...]

By |2022-05-19T14:55:19+00:00May 16th, 2022|0 Comments
Go to Top